An evaluation of estrogenic activity of parabens using uterine calbindin-D9k gene in an immature rat model

Toxicological Sciences

Volumn 112, Issue 1, 2009, Pages 68-77

  Vo, Thuy T B ^a   Jeung, Eui Bae ^a  

^a Chungbuk National University   (South Korea)

Author keywords

CaBP 9k; Endocrine disruptors; Parabens; Rat; Uterus

Indexed keywords

4 HYDROXYBENZOIC ACID ESTER; CALBINDIN; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; MESSENGER RNA; PROGESTERONE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ESTROGEN ACTIVITY; EXPERIMENTAL RAT; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; NONHUMAN; PERINATAL PERIOD; PREMATURITY; RAT; RNA TRANSLATION; TOXICOLOGY; UTERUS WEIGHT;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; DNA PRIMERS; ESTROGENS; FEMALE; MODELS, BIOLOGICAL; PARABENS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UTERUS;

RATTUS;

EID: 71049128180     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfp176     Document Type: Article

References (62)

1. An, B. S., Choi, K. C., Lee, G. S., Leung, P. C., and Jeung, E. B. (2004). Complex regulation of Calbindin-D(9k) in the mouse placenta and extra-embryonic membrane during mid- and late pregnancy. Mol. Cell. Endocrinol. 214, 39-52.
2. An, B. S., Kang, S. K., Shin, J. H., and Jeung, E. B. (2002). Stimulation of calbindin-D(9k) mRNA expression in the rat uterus by octyl-phenol, nonylphenol and bisphenol. Mol. Cell. Endocrinol. 191, 177-186.
3. Blair, R. M., Fang, H., Branham, W. S., Hass, B. S., Dial, S. L., Moland, C. L., Tong, W., Shi, L., Perkins, R., and Sheehan, D. M. (2000). The estrogen receptor relative binding affinities of 188 natural and xenochemicals: Structural diversity of ligands. Toxicol. Sci. 54, 138-153.
4. Byford, J. R., Shaw, L. E., Drew, M. G., Pope, G. S., Sauer, M. J., and Darbre, P. D. (2002). Oestrogenic activity of parabens in MCF7 human breast cancer cells. J. Steroid Biochem. Mol. Biol. 80, 49-60.
5. Choi, K. C., and Jeung, E. B. (2008). Molecular mechanism of regulation of the calcium-binding protein calbindin-D9k, and its physiological role(s) in mammals: A review of current research. J. Cell. Mol. Med. 12, 409-420.
6. Cicatiello, L., Scafoglio, C., Altucci, L., Cancemi, M., Natoli, G., Facchiano, A., Iazzetti, G., Calogero, R., Biglia, N., De Bortoli, M., et al. (2004). A genomic view of estrogen actions in human breast cancer cells by expression profiling of the hormone-responsive transcriptome. J. Mol. Endocrinol. 32, 719-775.
7. Dang, V. H., Nguyen, T. H., Choi, K. C., and Jeung, E. B. (2007). A calcium-binding protein, calbindin-D9k, is regulated through an estrogen-receptor mediated mechanism following xenoestrogen exposure in the GH3 cell line. Toxicol. Sci. 98, 408-415.
8. Darbre, P. D., Aljarrah, A., Miller, W. R., Coldham, N. G., Sauer, M. J., and Pope, G. S. (2004). Concentrations of parabens in human breast tumours. J. Appl. Toxicol. 24, 5-13.
9. Darbre, P. D., Byford, J. R., Shaw, L. E., Hall, S., Coldham, N. G., Pope, G. S., and Sauer, M. J. (2003). Oestrogenic activity of benzylparaben. J. Appl. Toxicol. 23, 43-51.
10. Darbre, P. D., Byford, J. R., Shaw, L. E., Horton, R. A., Pope, G. S., and Sauer, M. J. (2002). Oestrogenic activity of isobutylparaben in vitro and in vivo. J. Appl. Toxicol. 22, 219-226.
11. Diel, P., Schulz, T., Smolnikar, K., Strunck, E., Vollmer, G., and Michna, H. (2000). Ability of xeno- and phytoestrogens to modulate expression of estrogen-sensitive genes in rat uterus: Estrogenicity profiles and uterotropic activity. J. Steroid Biochem. Mol. Biol. 73, 1-10.
12. Donovan, K. A., Jacobsen, P. B., Andrykowski, M. A., Winters, E. M., Balducci, L., Malik, U., Kenady, D., and McGrath, P. (2004). Course of fatigue in women receiving chemotherapy and/or radiotherapy for early stage breast cancer. J. Pain Symptom Manage. 28, 373-380.
13. Frasor, J., Danes, J. M., Komm, B., Chang, K. C., Lyttle, C. R., and Katzenellenbogen, B. S. (2003). Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: Insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144, 4562-574.
14. Ge, J. H., and Chang, B. (2006). Estrogenic activities of parabens. Wei Sheng Yan Jiu 35, 650-652.
15. Golden, K. L., Collins, H. L., Loka, A. M., and Dicarlo, S. E. (2005). Gonadectomy and androgen replacement alter cardiac performance in conscious adult male rats. Clin. Exp. Hypertens. 27, 593-604.
16. Harvey, P. W. (2003). Parabens, oestrogenicity, underarm cosmetics and breast cancer: A perspective on a hypothesis. J. Appl. Toxicol. 23, 285-288.
17. Henry, D., Dobson, A., and Turner, C. (1993). Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology 105, 1078-1088.
18. Hong, E. J., Choi, K. C., and Jeung, E. B. (2003). Maternal-fetal transfer of endocrine disruptors in the induction of Calbindin-D9k mRNA and protein during pregnancy in rat model. Mol. Cell. Endocrinol. 212, 63-72.
19. Hong, E. J., Choi, K. C., and Jeung, E. B. (2004a). Induction of calbindin-D9k messenger RNA and protein by maternal exposure to alkylphenols during late pregnancy in maternal and neonatal uteri of rats. Biol. Reprod. 71, 669-675.
20. Hong, E. J., Choi, K. C., Jung, Y. W., Leung, P. C., and Jeung, E. B. (2004b). Transfer of maternally injected endocrine disruptors through breast milk during lactation induces neonatal calbindin-D9k in the rat model. Reprod. Toxicol. 18, 661-668.
21. Hossaini, A., Larsen, J. J., and Larsen, J. C. (2000). Lack of oestrogenic effects of food preservatives (parabens) in uterotrophic assays. Food Chem. Toxicol. 38, 319-323.
22. Howell, A., Robertson, J. F., Quaresma Albano, J., Aschermannova, A., Mauriac, L., Kleeberg, U. R., Vergote, I., Erikstein, B., Webster, A., and Morris, C. (2002). Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment. J. Clin. Oncol. 20, 3396-3403.
23. Inpanbutr, N., Miller, E. K., Petroff, B. K., and Iacopino, A. M. (1994). CaBP9K levels during the luteal and follicular phases of the estrous cycle in the bovine uterus. Biol. Reprod. 50, 561-571.
24. Inui, M., Adachi, T., Takenaka, S., Inui, H., Nakazawa, M., Ueda, M., Watanabe, H., Mori, C., Iguchi, T., and Miyatake, K. (2003). Effect of UV screens and preservatives on vitellogenin and choriogenin production in male medaka (Oryzias latipes). Toxicology 194, 43-50.
25. Jeung, E. B., Leung, P. C., and Krisinger, J. (1994). The human calbindin-D9k gene. Complete structure and implications on steroid hormone regulation. J. Mol. Biol. 235, 1231-1238.
26. Kang, J. S., Lee, B. J., Ahn, B., Kim, D. J., Nam, S. Y., Yun, Y. W., Nam, K. T., Choi, M., Kim, H. S., Jang, D. D., et al. (2003). Expression of estrogen receptor alpha and beta in the uterus and vagina of immature rats treated with 17-ethinyl estradiol. J. Vet. Med. Sci. 65, 1293-1297.
27. Kang, K. S., Che, J. H., Ryu, D. Y., Kim, T. W., Li, G. X., and Lee, Y. S. (2002). Decreased sperm number and motile activity on the F1 offspring maternally exposed to butyl p-hydroxybenzoic acid (butyl paraben). J. Vet. Med. Sci. 64, 227-235.
28. Kang, K. S., Kim, H. S., Ryu, D. Y., Che, J. H., and Lee, Y. S. (2000). Immature uterotrophic assay is more sensitive than ovariectomized uterotrophic assay for the detection of estrogenicity of p-nonylphenol in Sprague-Dawley rats. Toxicol. Lett. 118, 109-115.
29. Krisinger, J., Jeung, E. B., Simmen, R. C., and Leung, P. C. (1995). Porcine calbindin-D9k gene: Expression in endometrium, myometrium, and placenta in the absence of a functional estrogen response element in intron A. Biol. Reprod. 52, 115-123.
30. Krisinger, J., Setoyama, T., and Leung, P. C. (1994). Expression of calbindin-D9k in the early pregnant rat uterus: Effects of RU 486 and correlation to estrogen receptor mRNA. Mol. Cell. Endocrinol. 102, 15-22.
31. L'Horset, F., Blin, C., Brehier, A., Thomasset, M., and Perret, C. (1993). Estrogen-induced calbindin-D 9k gene expression in the rat uterus during the estrous cycle: Late antagonistic effect of progesterone. Endocrinology 132, 489-495.
32. Lee, G. S., Choi, K. C., Han, H. J., and Jeung, E. B. (2007). The classical and a non-classical pathways associated with NF-kappaB are involved in estrogen-mediated regulation of calbindin-D9k gene in rat pituitary cells. Mol. Cell. Endocrinol. 277, 42-50.
33. Lee, G. S., Choi, K. C., Kim, H. J., and Jeung, E. B. (2004). Effect of genistein as a selective estrogen receptor beta agonist on the expression of Calbindin-D9k in the uterus of immature rats. Toxicol. Sci. 82, 451-457.
34. Lee, G. S., Choi, K. C., Park, S. M., An, B. S., Cho, M. C., and Jeung, E. B. (2003). Expression of human Calbindin-D(9k) correlated with age, vitamin D receptor and blood calcium level in the gastrointestinal tissues. Clin. Biochem. 36, 255-261.
35. Lee, G. S., Kim, H. J., Jung, Y. W., Choi, K. C., and Jeung, E. B. (2005). Estrogen receptor alpha pathway is involved in the regulation of Calbindin-D9k in the uterus of immature rats. Toxicol. Sci. 84 270-277.
36. Lemini, C., Hernandez, A., Jaimez, R., Franco, Y., Avila, M. E., and Castell, A. (2004). Morphometric analysis of mice uteri treated with the preservatives methyl, ethyl, propyl, and butylparaben. Toxicol. Ind. Health 20, 123-132.
37. Lemini, C., Jaimez, R., Avila, M. E., Franco, Y., Larrea, F., and Lemus, A. E. (2003). In vivo and in vitro estrogen bioactivities of alkyl parabens. Toxicol. Ind. Health 19, 69-79.
38. Lemini, C., Silva, G., Timossi, C., Luque, D., Valverde, A., Gonzalez-Martinez, M., Hernandez, A., Rubio-Poo, C., Chavez Lara, B., and Valenzuela, F. (1997). Estrogenic effects of p-hydroxybenzoic acid in CD1 mice. Environ. Res. 75, 130-134.
39. Mitchell, G. V., Dua, P. N., Jenkins, M., and Grundel, E. (1989). Nutritional and pathological changes in male and female rats fed modifications of the AIN-76A diet. Food Chem. Toxicol. 27, 185-191.
40. Mosselman, S., Polman, J., and Dijkema, R. (1996). ER beta: Identification and characterization of a novel human estrogen receptor. FEBS Lett. 392, 49-53.
41. Nawaz, Z., Stancel, G. M., and Hyder, S. M. (1999). The pure antiestrogen ICI 182,780 inhibits progestin-induced transcription. Cancer Res. 59, 372-376.
42. Nephew, K. P., Long, X., Osborne, E., Burke, K. A., Ahluwalia, A., and Bigsby, R. M. (2000). Effect of estradiol on estrogen receptor expression in rat uterine cell types. Biol. Reprod. 62, 168-177.
43. Newbold, R. R., Jefferson, W. N., and Padilla-Banks, E. (2001). The mouse uterotrophic assay: Other end points. Environ. Health Perspect. 109, A569-A570.
44. Nguyen, T. H., Lee, G. S., Ji, Y. K., Choi, K. C., Lee, C. K., and Jeung, E. B. (2005). A calcium binding protein, calbindin-D9k, is mainly regulated by estrogen in the pituitary gland of rats during estrous cycle. Brain Res. Mol. Brain Res. 141, 166-173.
45. Ohta, Y., Sato, T., and Iguchi, T. (1993). Immunocytochemical localization of progesterone receptor in the reproductive tract of adult female rats. Biol. Reprod. 48, 205-213.
46. Oishi, S. (2001). Effects of butylparaben on the male reproductive system in rats. Toxicol. Ind. Health 17, 31-39.
47. Oishi, S. (2002a). Effects of butyl paraben on the male reproductive system in mice. Arch. Toxicol. 76, 423-429.
48. Oishi, S. (2002b). Effects of propyl paraben on the male reproductive system. Food Chem. Toxicol. 40, 1807-1813.
49. Oishi, S. (2004). Lack of spermatotoxic effects of methyl and ethyl esters of p-hydroxybenzoic acid in rats. Food Chem. Toxicol. 42 1845-1849.
50. Okubo, T., Yokoyama, Y., Kano, K., and Kano, I. (2001). ER-dependent estrogenic activity of parabens assessed by proliferation of human breast cancer MCF-7 cells and expression of ERalpha and PR. Food Chem. Toxicol. 39, 1225-1232.
51. Padilla-Banks, E., Jefferson, W. N., and Newbold, R. R. (2001). The immature mouse is a suitable model for detection of estrogenicity in the uterotropic bioassay. Environ. Health Perspect. 109, 821-826.
52. Pettersson, K., Grandien, K., Kuiper, G. G., and Gustafsson, J. A. (1997). Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha. Mol. Endocrinol. 11, 1486-1496.
53. Petz, L. N., Ziegler, Y. S., Loven, M. A., and Nardulli, A. M. (2002). Estrogen receptor alpha and activating protein-1 mediate estrogen responsiveness of the progesterone receptor gene in MCF-7 breast cancer cells. Endocrinology 143, 4583-4591.
54. Pugazhendhi, D., Sadler, A. J., and Darbre, P. D. (2007). Comparison of the global gene expression profiles produced by methylparaben, n-butylparaben and 17beta-oestradiol in MCF7 human breast cancer cells. J. Appl. Toxicol. 27, 67-77.
55. Routledge, E. J., Parker, J., Odum, J., Ashby, J., and Sumpter, J. P. (1998). Some alkyl hydroxy benzoate preservatives (parabens) are estrogenic. Toxicol. Appl. Pharmacol. 153, 12-19.
56. Shaw, J., and deCatanzaro, D. (2009). Estrogenicity of parabens revisited: Impact of parabens on early pregnancy and an uterotrophic assay in mice. Reprod. Toxicol. 28, 26-31.
57. Soni, M. G., Carabin, I. G., and Burdock, G. A. (2005). Safety assessment of esters of p-hydroxybenzoic acid (parabens). Food Chem. Toxicol. 43, 985-1015.
58. Tang, J. Y., Rampaul, R. S., and Cheung, K. L. (2008). The use of fulvestrant, a parenteral endocrine agent, in intestinal obstruction due to metastatic lobular breast carcinoma. World J. Surg. Oncol. 6 128.
59. Terasaka, S., Inoue, A., Tanji, M., and Kiyama, R. (2006). Expression profiling of estrogen-responsive genes in breast cancer cells treated with alkylphenols, chlorinated phenols, parabens, or bis- and benzoylphenols for evaluation of estrogenic activity. Toxicol. Lett. 163, 130-141.
60. Tinnanooru, P., Dang, V. H., Nguyen, T. H., Lee, G. S., Choi, K. C., and Jeung, E. B. (2008). Estrogen regulates the localization and expression of calbindin-D9k in the pituitary gland of immature male rats via the ERalpha-pathway. Mol. Cell. Endocrinol. 285, 26-33.
61. Vanparys, C., Maras, M., Lenjou, M., Robbens, J., Van Bockstaele, D., Blust, R., and De Coen, W. (2006). Flow cytometric cell cycle analysis allows for rapid screening of estrogenicity in MCF-7 breast cancer cells. Toxicol. In Vitro 20, 1238-1248.
62. Weisz, A., Basile, W., Scafoglio, C., Altucci, L., Bresciani, F., Facchiano, A., Sismondi, P., Cicatiello, L., and De Bortoli, M. (2004). Molecular identification of ERalpha-positive breast cancer cells by the expression profile of an intrinsic set of estrogen regulated genes. J. Cell. Physiol. 200, 440-450.